|
|
||||||||
Ann Thorac Surg 1991;52:541-543
© 1991 The Society of Thoracic Surgeons
The Brompton Hospital and King's College Hospital, London, United Kingdom
Accepted for publication January 16, 1991.
* Address reprint requests to Mr Bonser, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham B15 2TH, United Kingdom.
| Abstract |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. H. Levy, D. J. Freiberger, and J. Roback Review Article: Hereditary Angioedema: Current and Emerging Treatment Options Anesth. Analg., May 1, 2010; 110(5): 1271 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, O. Namura, T. Honma, and J.-i. Hayashi Supplementation of C1-esterase inhibitor concentrates for a patient suffering from hereditary angioedema undergoing complex open-heart surgery Eur J Cardiothorac Surg, April 1, 2010; 37(4): 975 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pecsi, G. H. Almassi, R. B. Bojrab, and P. S. Pagel Management of Hereditary Angioedema During Off-Pump Coronary Arterial Surgery Ann. Thorac. Surg., March 1, 2008; 85(3): 1079 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fattouch, G. Bianco, G. Speziale, R. Sampognaro, C. Lavalle, F. Guccione, P. Dioguardi, and G. Ruvolo Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study, Eur J Cardiothorac Surg, August 1, 2007; 32(2): 326 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Chaney, T. M. Adair, W. A. Lell, D. C. McGiffin, and V. G. Nielsen Hemostatic Analysis of a Patient with Hereditary Angioedema Undergoing Coronary Artery Bypass Grafting Anesth. Analg., December 1, 2001; 93(6): 1480 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Donatelli, G. Marchetto, M. Pocar, L. C. Zingale, M. Cicardi, and A. Grossi Does acquired angioedema increase the risk of surgery with cardiopulmonary bypass? J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 609 - 610. [Full Text] [PDF] |
||||
![]() |
M. Struber, J. T. Cremer, B. Gohrbandt, C. Hagl, M. Jankowski, B. Volker, H. Ruckoldt, M. Martin, and A. Haverich Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass Ann. Thorac. Surg., October 1, 1999; 68(4): 1330 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Videm, T. E. Mollnes, K. Bergh, E. Fosse, B. Mohr, T.-A. Hagve, A. O. Aasen, and J. L. Svennevig HEPARIN-COATED CARDIOPULMONARY BYPASS EQUIPMENT. II. MECHANISMS FOR REDUCED COMPLEMENT ACTIVATION IN VIVO J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 803 - 809. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||